RARA CRAFT DATABASE for FDA Medical Devices
510(k)K211567

FDA DEVICE FACTS

BiMobile Instruments (for BiMobile Dual Mobility System)

Waldemar Link GmbH & Co. KG

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEJune 3, 2022PRODUCT CODELZO

Indications for use

The BiMobile Dual Mobility System is indicated for patients with mobility-limiting diseases, fractures or defects of hip joint or proximal femur, which cannot be treated by conservative or osteosynthetic procedures. The BiMobile Dual Mobility System is indicated for the following conditions:

• Primary and secondary coxarthrosis

• Rheumatoid arthritis

• Correction of functional deformities

• Avascular Necrosis

• Femoral neck fractures

• Revision after implant loosening dependent on bone mass and quality

• Dislocation risks The device is intended for cemented and cementless use. Technological Characteristics and Substantial Equivalence The modified Class II accessory instruments within the BiMobile Instrument system that are the subjects of this 510(k) have the same intended use, operating principle, bas ic device designs and purposes, and materials as the unmodified instruments. The modified impactor handles with the corresponding impactor expanders create the same impaction of the shells, but feature minor design changes for simplicity and ease of use. The substantial equivalence of the modified to the original instruments was supported by non-clinical testing and evaluations including:

- Simulated transport testing

- Biocompatibility assessment

- Interface analysis, functional testing, biolab evaluation, application risk analysis

- Durability testing

- Validation of reprocessing and sterilization instructions

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 22, 2026